DHR Stock Price Today (October 2026) — Danaher Corporation Analysis & Key Metrics 2026-10-20
Danaher Corporation (DHR) is trading at $224.24, down 0.08% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $244.14 (8.9% upside).
- Volatility is moderate (27.70% annualized), implying notable price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (5.50% YoY) alongside competitive pressures in the Diagnostics & Research space.
DHR Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Danaher Corporation - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $181.15B
P/E Ratio
Forward P/E: 22.97
Revenue Growth
Year over Year
Analyst Target
+8.9% upside potential
Key Investor Questions About DHR
What investors need to know before buying
Based on current market data, DHR presents a neutral technical setup with looking solid fundamentals.
- Technicals say: Neutral (RSI 55.12)
- Fundamentals say: Looking solid (debt and growth supportive)
DHR's growth trajectory depends on its ability to expand within the Diagnostics & Research sector while managing margin pressures.
- Future growth will depend on performance in core Diagnostics & Research operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for DHR investors include debt exposure and competitive dynamics in the Diagnostics & Research industry.
- $27.86B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Diagnostics & Research.
52-Week Trading Range
Over the past year, DHR stock traded between $160.93 and $242.80 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 27.70% annualized volatility and β=0.63, the stock exhibits low sensitivity to market moves—making DHR suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows
3 S&P 500 Stocks We Find Risky
Danaher (DHR) Reports Q3: Everything You Need To Know Ahead Of Earnings
8 Stocks That Are Much Riskier Plays Than They Look
Masimo’s vitals monitor scoops FDA clearance for AFib detection
Latest TickZen Insights
All insights →No TickZen article on DHR yet. Our newest analysis:
Explore More Analysis for DHR
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 21, 2026 (before the open)
Frequently Asked Questions
Common investor questions about Danaher Corporation
Danaher Corporation (DHR) is currently trading at $224.24. The RSI (14-day) is at 55.1, indicating neutral territory. Wall Street analysts have a consensus "strong_buy" recommendation. The mean analyst price target of $244.14 implies 8.9% upside from current levels. Volatility is moderate at 27.7% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Danaher Corporation (DHR): The trailing P/E ratio is 36.17, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 22.97, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.41, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 2.72. Price-to-Sales is 5.69. Valuation should be compared to Diagnostics & Research industry peers for context, as different sectors trade at different multiples.
Based on 22 analysts covering DHR, the consensus price target is $244.14. This represents a 8.9% upside from the current price of $224.24. The range spans from a low target of $200.00 to a high target of $310.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "strong_buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Danaher Corporation (DHR) pays a dividend with a current yield of approximately 0.72%. The annualized dividend rate is $1.44 per share. The payout ratio is 25.7%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was Sep 30, 2026.
Key risks for Danaher Corporation (DHR) investors include: 1. Moderate volatility (27.7% annualized)—price swings are notable. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Diagnostics & Research sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Danaher Corporation's (DHR) current debt and financial health profile: Total debt stands at $27.86B. The debt-to-equity ratio is 0.53x, which is moderate and generally manageable for most companies. The current ratio is 1.65, indicating strong short-term liquidity. The quick ratio is 1.15. The company holds $4.35B in cash and equivalents. Free cash flow is positive at $4.33B, providing a cushion for debt servicing and shareholder returns.